Sterile fill-finish is recognized as one of the most critical steps in pharmaceutical production. Aseptic conditions during this stage are essential for ensuring both product quality and patient ...

(MENAFN- GlobeNewsWire - Nasdaq) The fill-finish pharmaceutical contract manufacturing market is poised for growth, driven by the demand for specialized manufacturing of complex small molecule drugs.

Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future ...

When considering manufacturing and the growth of drug formulation, it is evident that there has been change and many new advancements introduced to make processes more efficient. When considering ...

CLEVELAND--(BUSINESS WIRE)--Lubrizol Life Science Health, a leading pharmaceutical company, has won the Finished Formulation Award at CPhI Barcelona for its innovative technology – Apisolex™ Polymer ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

BASEL, Switzerland, March 11, 2025 /PRNewswire/ -- CordenPharma, a leading Contract Development & Manufacturing Organization (CDMO) specializing in the supply of peptide APIs and peptide-based ...

CPhI Korea ,the leading pharmaceutical exhibition in Korea, with a new co-located event entirely dedicated to Finished Dosage Formulation (FDF), is set to return to Seoul from August 28 to 30, 2018 ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service ...